Deubiquitination and Stabilization of PD-L1 by CSN5-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Deubiquitination and Stabilization of PD-L1 by CSN5

Published:2016-12 Issue:6 Volume:30 Page:925-939
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Lim Seung-Oe,Li Chia-Wei,Xia Weiya,Cha Jong-Ho,Chan Li-Chuan,Wu Yun,Chang Shih-Shin,Lin Wan-Chi,Hsu Jung-Mao,Hsu Yi-Hsin,Kim Taewan,Chang Wei-Chao,Hsu Jennifer L.,Yamaguchi Hirohito,Ding Qingqing,Wang Yan,Yang Yi,Chen Chung-Hsuan,Sahin Aysegul A.,Yu Dihua,Hortobagyi Gabriel N.,Hung Mien-Chie

Funder

NIH

Cancer Prevention Research Institute of Texas

Patel Memorial Breast Cancer Endowment Fund

National Breast Cancer Foundation

Breast Cancer Research Foundation

University of Texas MD Anderson Cancer Center

China Medical University

Hospital Sister Institution Fund

Ministry of Science and Technology

International Research-intensive Centers of Excellence

Ministry of Health and Welfare

Center for Biological Pathways

Cure Postdoctoral Fellowship

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference40 articles.

1. Anticancer potential of curcumin: preclinical and clinical studies;Aggarwal;Anticancer Res.,2003

2. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system;Bech-Otschir;EMBO J.,2001

3. NF-kappaB signaling pathways regulated by CARMA family of scaffold proteins;Blonska;Cell Res.,2011

4. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates;Brahmer;J. Clin. Oncol.,2010

5. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production;Brown;J. Immunol.,2003

Cited by 571 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of PFKFB3 as a key factor in the development of colorectal cancer and immunotherapy resistance;Clinical and Experimental Medicine;2024-09-12

2. Bridging the Gap: Immune Checkpoint Inhibitor as an Option in the Management of Advanced and Recurrent Cervical Cancer in Sub-Saharan Africa;Cureus;2024-09-10

3. GOLM1 dictates acquired Lenvatinib resistance by a GOLM1-CSN5 positive feedback loop upon EGFR signaling activation in hepatocellular carcinoma;Oncogene;2024-09-09

4. Zosuquidar Promotes Antitumor Immunity by Inducing Autophagic Degradation of PD‐L1;Advanced Science;2024-09-04

5. NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10;Cell Communication and Signaling;2024-09-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3